|
Gerson Pharma Solutions is devoted to helping
pharmaceutical companies design and execute their
preclinical drug development programs, interpreting
the findings and most importantly putting the findings
into perspective. Extensive experience in
toxicology; broad-based experience in Drug Metabolism,
Pharmacokinetics and Pharmacology; Gerson
Pharma Solutions can fulfill many of your company's
preclinical drug development needs. |
|
A board-certified Toxicologist with over 25 years of
preclinical drug development experience, Dr. Gerson
has written or directed the preparation of over
thirty nonclinical IND packages for products
from a broad variety of therapeutic areas. He has
also progressed several drugs from discovery/early
development through successful worldwide
registration including authoring of the nonclinical
NDA/MAA eCTD packages. He also has experience in the
development of drug delivery devices, medical
imaging agents and has led many diligence teams
evaluating potential in-licensing candidates and
corporate acquisitions. |
